Advertisement

Topics

"T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs" Drugs and Medication Database

19:12 EDT 14th August 2018 | BioPortfolio

Here are the most relevant "T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs" Drugs and Medications that we have found in our database.

More Information about "T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs" on BioPortfolio

We have published hundreds of T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs news stories on BioPortfolio along with dozens of T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs Clinical Trials and PubMed Articles about T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs Companies in our database. You can also find out about relevant T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs Drugs and Medications on this site too.

Showing "Patients With Prior Drug Treatment Resistance Each Three" Drugs and Medications 1–25 of 27

Possibly Relevant

Emtriva [Gilead Sciences, Inc.]

These highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA.EMTRIVA (emtricitabine) capsule for oral useEMTRIVA (emtricitabine) solution for oral useInitial U.S. Approval:

Selzentry [Pfizer Laboratories Div Pfizer Inc]

These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) TabletsInitial U.S. Approval: 2007

Ganciclovir [Bedford Laboratories]

GANCICLOVIR FOR INJECTION USP

Cytovene [Genentech, Inc.]

CYTOVENE-IV (ganciclovir sodium for injection)

Topiramate [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use topiramate safely and effectively. See full prescribing information for topiramate tablets.Topiramate Tablets for Oral UseInitial U.S. Approval – 1996

Ganciclovir [APP Pharmaceuticals, LLC]

Topiramate [Greenstone LLC]

These highlights do not include all the information needed to use topiramate safely and effectively. See full prescribing information for topiramate tablets.topiramate tablets for oral useInitial U.S. Approval – 1996

Nystatin [Dispensing Solutions, Inc.]

NYSTATIN CREAM, USP

Nystatin [Qualitest Pharmaceuticals]

NYSTATIN CREAM, USP

Baraclude [E.R. Squibb & Sons, L.L.C.]

These highlights do not include all the information needed to use BARACLUDE safely and effectively. See full prescribing information for BARACLUDE. BARACLUDE (entecavir) Tablets BARACLUDE (entecavir) Oral Solution Initial U.S. Approval: 2005

Aidplus sting relief prep pad [Planet (Suzhou) Medical Products Co. Ltd]

AidPlus STING RELIEF PREP PADS

Nystop [Paddock Laboratories, Inc. ]

Nystop Nystatin Topical Powder USP

Nystatin [Physicians Total Care, Inc.]

Nystop Nystatin Topical Powder USP

Docetaxel [Winthrop U.S.]

These highlights do not include all the information needed to use docetaxel safely and effectively. See full prescribing information for docetaxel.  Docetaxel Injection Concentrate, Intravenous Infusion (IV). Initial U.S. Approval: 1996

Nystatin [Midlothian Laboratories, Inc.]

NYSTATIN TOPICAL POWDER, USP

Taxotere [sanofi-aventis U.S. LLC]

These highlights do not include all the information needed to use TAXOTERE safely and effectively. See full prescribing information for TAXOTERE. TAXOTERE (docetaxel) Injection Concentrate, Intravenous Infusion (IV). Initial U.S. Approval: 1996

Taxotere [sanofi-aventis U.S. LLC]

These highlights do not include all the information needed to use TAXOTERE safely and effectively. See full prescribing information for TAXOTERE.  TAXOTERE (docetaxel) Injection Concentrate, Intravenous Infusion (IV). Initial U.S. Approval: 1996

Clotrimazole [STAT RX USA LLC]

Clotrimazole [Glenmark Generics Inc., USA]

Clotrimazole Cream USP, 1%

Clotrimazole [TEVA Pharmaceuticals USA Inc]

CLOTRIMAZOLE TOPICAL SOLUTION, USP 1%0248FOR DERMATOLOGIC USE ONLYNOT FOR OPHTHALMIC USE

Docetaxel [Hospira, Inc.]

These highlights do not include all the information needed to use Docetaxel Injection safely and effectively. See full prescribing information for Docetaxel.Docetaxel Injection,For intravenous infusion only.Initial U.S. Approval: 1996

Clotrimazole [Taro Pharmaceuticals U.S.A., Inc.]

CLOTRIMAZOLE CREAM USP, 1%

Docetaxel [Accord Healthcare Inc.]

These highlights do not include all the information needed to use Docetaxel Injection safely and effectively. See full prescribing information for Docetaxel Injection. Docetaxel Injection, Intravenous Infusion. Initial U.S. Approval: 1996

Nystatin [Taro Pharmaceuticals U.S.A., Inc.]

Nystatin Cream USP, 100,000 units per gram

Nystatin [Perrigo New York Inc]

NYSTATIN CREAM USP



Advertisement
Quick Search
Advertisement
Advertisement